Myriad Genetics Inc (MYGN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
7.42 +0.05 (+0.68%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 7.42 unch (unch) 16:01 ET
for Fri, Apr 25th, 2025
Results
download Want to compare other data? Select FieldsSymbol | MYGN | ZYME | PHVS | ||
Company | Myriad Genetics Inc | Zymeworks Inc | Pharvaris N.V. | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 7.31 | 12.41 | 16.09 | ||
High | 7.43 | 12.58 | 17.22 | ||
Low | 7.16 | 12.23 | 16.02 | ||
Last | 7.42 | 12.57 | 16.84 | ||
Change | +0.05 | +0.05 | +1.01 | ||
% Change | +0.68% | +0.40% | +6.38% | ||
Volume | 2,666,800 | 370,300 | 560,100 | ||
20-Day Average Volume | 1,385,955 | 825,770 | 61,260 | ||
Previous Close | 7.37 | 12.52 | 15.83 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | No | ||
Technicals | |||||
20-Day Moving Average | 8.03 | 11.35 | 14.14 | ||
20-Day Raw Stochastic | 11.45% | 90.77% | 93.35% | ||
20-Day Relative Strength | 30.29% | 53.96% | 59.75% | ||
Weighted Alpha | -69.43 | +30.26 | -25.60 | ||
Today's Opinion | 100% Sell | 48% Sell | 56% Sell | ||
Previous Opinion | 100% Sell | 48% Sell | 64% Sell | ||
Last Month's Opinion | 100% Sell | 40% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -2.88% since 04/17/25 | +9.02% since 04/17/25 | +20.29% since 04/17/25 | ||
Low | 7.16 on 04/25/25 | 11.34 on 04/21/25 | 13.81 on 04/21/25 | ||
High | 7.89 on 04/23/25 | 12.93 on 04/23/25 | 17.22 on 04/25/25 | ||
1-Month | |||||
%Chg | -23.74% since 03/25/25 | -1.80% since 03/25/25 | +10.43% since 03/25/25 | ||
Low | 7.16 on 04/25/25 | 9.03 on 04/10/25 | 11.51 on 04/10/25 | ||
High | 9.88 on 03/26/25 | 12.93 on 04/23/25 | 17.22 on 04/25/25 | ||
3-Month | |||||
%Chg | -42.12% since 01/24/25 | -13.85% since 01/24/25 | -10.14% since 01/24/25 | ||
Low | 7.16 on 04/25/25 | 9.03 on 04/10/25 | 11.51 on 04/10/25 | ||
High | 15.47 on 02/19/25 | 15.25 on 02/18/25 | 19.04 on 01/27/25 | ||
6-Month | |||||
%Chg | -65.58% since 10/25/24 | -2.78% since 10/25/24 | -22.43% since 10/25/24 | ||
Low | 7.16 on 04/25/25 | 9.03 on 04/10/25 | 11.51 on 04/10/25 | ||
High | 22.92 on 10/30/24 | 17.70 on 11/12/24 | 25.50 on 11/04/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 749,350 | 761,868 | 746,701 | ||
Shares Outstanding, K | 92,171 | 69,577 | 52,290 | ||
Annual Sales | 837,600,000 | 76,300,000 | 0 | ||
Annual Net Income | -127,300,000 | -122,700,000 | -145,240,000 | ||
Last Quarter Sales | 210,600,000 | 31,030,000 | 0 | ||
Last Quarter Net Income | -42,500,000 | -23,510,000 | -36,940,000 | ||
60-Month Beta | 1.87 | 1.18 | -2.84 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.03 on 02/24/25 | -0.31 on 03/05/25 | -0.68 on 04/07/25 | ||
Latest Earnings Date | 05/06/25 | 05/08/25 | 05/14/25 | ||
Most Recent Dividend | 1.750 on 06/15/09 | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |